$FEMY

FEMASYS INC (FEMY): Submission of Matters to a Vote of Security Holders

FEMASYS INC (FEMY) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001339005 0001339005 2026-06-24 2026-06-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2026

Original reporting
Published Jun 24, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$FEMY
Neutral
high confidence
Mentioned
$FEMY
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FEMYNeutralLow
01

Why it matters

The disclosure confirms board director elections (two Class II directors) and ratifies KPMG LLP as independent registered accounting firm for the fiscal year ending Dec. 31, 2026; it does not include new financial results, guidance, or corporate actions beyond the reverse split adjustment context.

02

Market read

This is a governance/voting confirmation filing; absent additional disclosures, it is unlikely to drive a fundamental repricing.

03

What to watch

Traders may still check whether any director election was contested or whether auditor ratification faced meaningful opposition, but this 8-K does not quantify implications beyond vote counts.

Relevance 6/10Novelty 2/10Timing: post-close/after-hours following the June 24 annual meeting vote disclosure

Background

The filing is an SEC Form 8-K (Item 5.07) reporting matters submitted to a vote of security holders at Femasys’ June 24, 2026 annual meeting, with vote totals adjusted for a 1-for-20 reverse stock split on June 5, 2026.

Company-level read

Ticker impact

$FEMYNeutralHigh confidence
Context

Femasys reported June 24, 2026 annual meeting vote results, including director elections and ratification of KPMG as auditor for 2026.

Expected impact

Limited near-term impact; any reaction likely reflects low-information governance housekeeping rather than fundamentals.

Evidence & confidence

The 8-K item 5.07 only provides voting tallies for board seats and auditor ratification, with no new business developments or financial datapoints.

Market effects

None; governance/auditor ratification does not change sector fundamentals.

None indicated.

None indicated.

Counterpoint

If the vote results imply contested governance (e.g., unusually high against/abstain), it could hint at shareholder dissatisfaction, but the filing provides no narrative or follow-on actions.

Key entities

  • Femasys Inc.

    Nasdaq-listed issuer filing the 8-K and reporting annual meeting vote outcomes.

  • KPMG LLP

    Independent registered accounting firm ratified by shareholders for fiscal year ending Dec. 31, 2026.

  • Charles Larsen

    Elected as Class II director based on the reported vote totals.

  • Kenneth Eichenbaum

    Elected as Class II director based on the reported vote totals.

Related articles

$FEMYMedAI 8/10

Femasys Stock Falls 11% Over Announcement Of $30 Mln Private Placement

Femasys Inc. (FEMY) shares fell 11.07% to $2.65 after the company announced a $30 million private placement on Nasdaq. Femasys will sell 9.37 million shares plus pre-funded warrants and warrants for 18.75 million shares, priced at $3.20. Lead investor is Nantahala Capital, with others including Rosalind Advisors. Potential extra cash proceeds up to $60 million if warrants are exercised.

$FEMYMedAI 8/10

Femasys Inc.: Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million

Femasys Inc. (NASDAQ: FEMY) said it entered a $30 million private placement with accredited investors led by Nantahala Capital, with participation from other healthcare funds and management. It will sell 9,374,999 shares plus pre-funded and accompanying warrants. If all warrants are exercised, Femasys could receive up to $60 million more. Closing is expected around Aug. 10, 2026.

SK Hynix said to mull options for US$3 billion Chongqing plant

SK Hynix is considering options for its Chongqing, China semiconductor packaging and testing facility, including possibly bringing in an investor to accelerate growth. People familiar said a potential stake sale could value the plant at about US$3 billion and SK Hynix may keep a minority stake. Separately, it plans a 54 trillion won (US$38 billion) South Korea expansion for DRAM and NAND.

$ZGMed

Zillow Lays Off 500+ Employees Amid $4 Million Q2 Net Loss

Zillow Group said Aug. 4 it will cut more than 500 jobs, about 7% of staff, its second layoff round this year after 200 cuts in January. The company reported Q2 2026 revenue of $772 million, up 18% year over year, but a $4 million net loss driven by a $36 million restructuring charge, citing a flat housing market.

$SNRGMed

Trump administration to invest $3 billion into minerals projects to boost defense supply

The Trump administration said it will invest $3 billion in US critical-minerals projects to support defense supply. The Pentagon’s Office of Strategic Capital plans conditional loans of $1.4B to Sila Nanotechnologies, $400M to Sunrise Energy Metals, and $150M to Niron Magnetics. The Export-Import Bank will lend $58M to several firms, while DOE and Pentagon grants target mining education.

$MSTRMed

What Is Strategy (MSTR) Planning With Its $15 Billion Bitcoin Backed Preferred Stock?

Strategy Inc (MSTR) says it has launched a Bitcoin-backed preferred stock structure, backed by its Bitcoin holdings, and raised about $15 billion, according to the company. Management describes it as a “capital flywheel” to fund future digital-asset initiatives. The article notes Strategy’s recent large net losses and highlights upcoming dividend and cash-flow tests.